右心室 - 肺动脉合在门干预中的预后价值:系统性审查和元分析
Vitaliy Androshchuk1, Edouard Long1, Omar Chehab1
1School of Cardiovascular Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
JACC. Cardiovascular interventions
|December 16, 2025
概括
通过TAPSE/PASP测量的右心室-肺动脉 (RV-PA) 合,预测大动脉狭窄和 mitrale regurgitation干预后的死亡率. 特定的RV-PA切割值可以改善风险分层,以便更好地选择患者.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 右心室 - 肺动脉 (RV-PA) 合对于膜性心脏病的预后至关重要.
- 了解RV-PA合在干预后的作用对于患者管理至关重要.
研究的目的:
- 系统地审查和元分析RV-PA合与主动脉狭窄症 (AS), mitra regurgitation (MR) 和三 regurgitation (TR) 的干预后的临床结果之间的关联.
- 为了确定最佳的RV-PA合值来预测不良事件.
主要方法:
- 30项干预研究的系统综述和元分析 (N=12,992).
- 主要结局:全因死亡率. 二级结局:主要心血管不良事件 (MACE).
- 用于聚合估计的随机效应模型;用于值识别的ROC曲线.
主要成果:
- 降低三 annular 平面缩外流到肺动脉缩压力 (TAPSE/PASP) 的比率独立地与AS和MR干预中增加的死亡率和MACE有关.
- 在TAPSE/PASP与AS和MR的不良结果之间观察到显著的非线性关联.
- 已确定用于预测死亡率的最佳TAPSE/PASP值:≤0.51 mm/mm Hg (AS),≤0.33 mm/mm Hg (MR),≤0.44 mm/mm Hg (TR). 通过测试,可以预测死亡率.
结论:
- TAPSE/PASP是AS和MR干预后结果的独立预测器.
- 特定疾病的TAPSE/PASP切割值可以增强门干预的风险分层模型.
- 整合这些截止值可能会改善干预前死亡率预测和患者选择.
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
01:22Mitral Stenosis I: Introduction
386
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
386
01:20Mitral Regurgitation I: Introduction
371
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
371
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
330
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
330
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
194
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
194
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277